BR112021002523A2 - método para preparar um composto - Google Patents

método para preparar um composto Download PDF

Info

Publication number
BR112021002523A2
BR112021002523A2 BR112021002523-5A BR112021002523A BR112021002523A2 BR 112021002523 A2 BR112021002523 A2 BR 112021002523A2 BR 112021002523 A BR112021002523 A BR 112021002523A BR 112021002523 A2 BR112021002523 A2 BR 112021002523A2
Authority
BR
Brazil
Prior art keywords
formula
compound
7alkyl
halogen
7alkoxy
Prior art date
Application number
BR112021002523-5A
Other languages
English (en)
Portuguese (pt)
Inventor
Qing Ri LI
Hee Kyoon Yoon
Original Assignee
Daewoong Pharmaceutical Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daewoong Pharmaceutical Co., Ltd. filed Critical Daewoong Pharmaceutical Co., Ltd.
Publication of BR112021002523A2 publication Critical patent/BR112021002523A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H7/00Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
    • C07H7/06Heterocyclic radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
BR112021002523-5A 2018-08-13 2019-08-09 método para preparar um composto BR112021002523A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR10-2018-0094261 2018-08-13
KR20180094261 2018-08-13
PCT/KR2019/010123 WO2020036382A1 (ko) 2018-08-13 2019-08-09 Sglt 저해제의 합성에 유용한 중간체의 제조

Publications (1)

Publication Number Publication Date
BR112021002523A2 true BR112021002523A2 (pt) 2021-05-04

Family

ID=69525610

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112021002523-5A BR112021002523A2 (pt) 2018-08-13 2019-08-09 método para preparar um composto

Country Status (13)

Country Link
US (1) US11661406B2 (de)
EP (1) EP3838894B1 (de)
JP (1) JP7146067B2 (de)
KR (1) KR102307475B1 (de)
CN (1) CN112585124B (de)
BR (1) BR112021002523A2 (de)
CA (1) CA3109107C (de)
CO (1) CO2021001857A2 (de)
ES (1) ES2980368T3 (de)
MX (1) MX2021001732A (de)
PE (1) PE20211206A1 (de)
PH (1) PH12021550297A1 (de)
WO (1) WO2020036382A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102572714B1 (ko) * 2020-02-27 2023-08-31 주식회사 대웅제약 Sglt 저해제의 합성에 유용한 중간체 및 이를 이용한 sglt 저해제의 제조 방법
KR102693201B1 (ko) * 2020-09-10 2024-08-08 주식회사 대웅제약 Sglt 저해제 중간체의 합성 방법
KR20230110001A (ko) * 2022-01-14 2023-07-21 주식회사 대웅제약 Ssglt 저해제의 합성에 유용한 중간체의 제조 방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009014970A1 (en) 2007-07-26 2009-01-29 Lexicon Pharmaceuticals, Inc. Methods and compounds useful for the preparation of sodium glucose co-transporter 2 inhibitors
ES2719656T3 (es) * 2011-06-01 2019-07-11 Green Cross Corp Derivados de difenilmetano novedosos como inhibidores del SGLT2
US9340521B2 (en) * 2013-03-18 2016-05-17 Green Cross Corporation Method for dual inhibition of SGLT1 and SGLT2 using diphenylmethane derivatives
AU2014317663B2 (en) 2013-09-09 2018-02-08 Youngene Therapeutics Co., Ltd. C-aryl glucoside derivative, preparation method for same, and medical applications thereof
HRP20211670T8 (hr) 2016-06-17 2022-03-18 Daewoong Pharmaceutical Co., Ltd. Derivat difenilmetana u kristalnom obliku
KR101770302B1 (ko) 2016-06-28 2017-08-22 주식회사 녹십자 다이페닐메탄 유도체의 제조방법
CN110337442B (zh) * 2017-02-24 2023-05-12 东亚St株式会社 作为2型钠依赖性葡萄糖转运蛋白抑制剂的新型葡萄糖衍生物

Also Published As

Publication number Publication date
EP3838894A1 (de) 2021-06-23
CN112585124A (zh) 2021-03-30
PE20211206A1 (es) 2021-07-05
CO2021001857A2 (es) 2021-02-26
EP3838894B1 (de) 2024-03-13
WO2020036382A1 (ko) 2020-02-20
JP7146067B2 (ja) 2022-10-03
CA3109107A1 (en) 2020-02-20
US11661406B2 (en) 2023-05-30
EP3838894A4 (de) 2022-04-20
PH12021550297A1 (en) 2021-10-11
MX2021001732A (es) 2021-06-23
KR102307475B1 (ko) 2021-09-30
US20210292291A1 (en) 2021-09-23
JP2021534174A (ja) 2021-12-09
CN112585124B (zh) 2024-04-19
CA3109107C (en) 2023-04-25
KR20200019092A (ko) 2020-02-21
ES2980368T3 (es) 2024-10-01

Similar Documents

Publication Publication Date Title
BR112021002523A2 (pt) método para preparar um composto
JPWO2008075736A1 (ja) C−グリコシド誘導体の製造方法及びその合成中間体
JP3848837B2 (ja) 新規な中間体、それを用いたマイクロライド系抗生物質の製造方法
JP3304098B2 (ja) エリスロマイシン誘導体の10位のメチル基の新規な異性化方法
KR101308258B1 (ko) 엔독시펜의 신규한 제조 방법
JP2018512066A (ja) デオキシコール酸の作製方法
Bharucha et al. The conversion of hyodesoxycholic acid to progesterone
EP0080819B1 (de) 11-0-Alkylerythromycin A Derivate
JP6923520B2 (ja) 新規な5−アジド−5−デオキシ−2:3−イソプロピリデン−D−アラビノース化合物、それらの製造方法、およびAra−N3、Kdo−N3および4eKdo−N3の合成のためのそれらの使用
JPH0797391A (ja) ヌクレオシド誘導体とその製造方法
JP3029806B2 (ja) コルヒチン誘導体をグリコシド化する方法、及びその生成物
JP4691101B2 (ja) 1−α−ハロ−2,2−ジフルオロ−2−デオキシ−D−リボフラノース誘導体及びその製造方法
JP5305697B2 (ja) α−D−マンノピラノシド誘導体の製造方法
EP1688409B1 (de) Von vitamin d abgeleitete monohalogenvinylverbindungen
JPS63145296A (ja) 5−トリフルオロメチル−2’−デオキシ−β−ウリジン類の製造方法
JP2007513134A (ja) 2−置換アデノシンの改善された合成
PL187648B1 (pl) Sposób wytwarzania pochodnej deoksyurydyny
JP3703509B2 (ja) D−マンノサミン誘導体の製造方法
JP3978006B2 (ja) エリスロマイシン誘導体の製造方法
PT93800A (pt) Processo para preparacao de derivados da glucosaminil-epi-podofilotoxina
JP2750170B2 (ja) ステロイド誘導体の製造法
KR100550160B1 (ko) 알부틴 및 알파형 알부틴 제조용 중간체의 제조방법
JP2005538080A (ja) 2−デオキシ−l−リボースの合成方法
JP2007204490A (ja) エリスロマイシン誘導体の製造方法
JPH0616667A (ja) ピラゾロ[1,5−aピリジン誘導体の新規製造方法

Legal Events

Date Code Title Description
B15K Others concerning applications: alteration of classification

Free format text: AS CLASSIFICACOES ANTERIORES ERAM: C07D 307/82 , C07D 409/04 , C07H 7/06 , C07H 1/00

Ipc: C07D 307/82 (2006.01), C07D 409/04 (2006.01), C07H

B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]